Cannabis employment opportunities and pharmaceutical cannabis cultivation jobs are a hot topic in the medicinal marijuana sector around the globe. With Australia poised to become a major medical marijuana production exporter in the global medicinal cannabis and exportation marketplace, PharmOut announced the launch of a Medicinal Cannabis Academy. Estimated read time: 2 minutes.
Cannabis Cultivation and Production Training and Employment Trends
The Medicinal Cannabis Academy is designed to meet the specialised training needs of a rapidly growing employment sector. New job creation predictions for pharmaceutical-grade cannabis cultivation and production employment suggest several thousand new workers will be required over the next few years. Gaining employment in the cannabis industry in Australia will require specialised horticultural abilities, security training, GMP and safety reporting adherence, agricultural cultivation and exportation expertise and facility management skills. These skills will be specific to job roles in medical-grade cannabis manufacturing and GMP facility management including production, manufacturing, security and export sector(s).
New Jobs expected in Medical Cannabis production and exportation business start-ups in Australia
New jobs created in the Cannabis Industry are expected to exceed 10,000 employment opportunities by 2024-2025.
Responding to the 10,000 new Australian jobs expected in medicinal cannabis cultivation in Australia over the next few years, PharmOut announced that it will invest in a multimillion-dollar state of the art Medicinal Cannabis Academy. The Australian based training academy will offer cannabis start-up businesses and pharmaceutical companies practical training in the growing and processing of Medicinal Cannabis (medical marijuana) into pharmaceutical grade cannabis products and dosage forms.
Medicinal Cannabis Academy – Advanced Cannabis Cultivation Training – Plus 1-Day Masterclass Options
The Medicinal Cannabis Academy will expand PharmOut’s existing global leadership in the areas of Good Agricultural and Collection Practices (GACP), Good Manufacturing Practices (GMP), consulting and training.
Commencing in 2019, the Medicinal Cannabis Academy will help cultivators, manufacturers, exporters and job seekers meet the medicinal cannabis industry’s estimated demand for 10,000 new regional workers over the next two years.
Trevor Schoerie, PharmOut’s Managing Director commented “Medicinal Cannabis cultivation and processing is an exciting global phenomenon. Australia’s reputation for good agricultural practices and compliance, added to the favourable Australian climate and land availability, has seen hundreds of millions of dollars being invested into the region. Given this is a brand-new industry, there is a substantial knowledge gap. Our plan is to help cultivators, manufacturers and their workforce learn about propagation, cultivation, harvesting and processing and to help them meet the stringent regulatory standards required for both local and export markets.”
In looking to leverage early global mover advantage, Medicinal Cannabis companies are moving quickly to secure large export contracts.
Maria Mylonas, PharmOut’s Learning and Development Director, is equally excited about expanding PharmOut’s existing educational services, saying “PharmOut is frequently asked for guidance by the industry looking to recruit staff experienced in cannabis cultivation and processing under a framework of Good Agricultural Collection Practices (GACP) and Good Manufacturing Practices (GMP) as required by the regulators. At the same time, there are job seekers looking for opportunities to establish a career in this interesting growth sector. PharmOut has over 10 years’ experience in training Pharmaceutical industry employees and the Academy is a natural extension of what we do.”
According to a report by Global Market Insights, the global medicinal cannabis industry was estimated to be worth more than US$ 11 Billion in 2017 and projected to surpass $US 55 billion by 2024. So far, the global market for cannabis has exceeded initial estimates and expectations, leading to revised forecasts by investor experts.
While cannabis laws and regulatory policies remain in development worldwide as well as in Australia, Australia legalised cannabis for medicinal use in October 2016 creating strong interest from international and local investors. There is currently an estimated investment of over 2 million square meters in new greenhouse capacity in Australia, specifically focused on meeting the global market demand for Medicinal Cannabis. Canadian Company, Asterion, recently announced the Australian Government Awarding of Major Project Status for their Australian entity’s $450 million Toowoomba Medicinal Cannabis Project. Asterion estimates the requirement for a full-time workforce of 800 as well as an additional 300 part-time and shift-based positions. The project is planned to commence in the last quarter of 2019.
But as more start-up investors explore this lucrative growth market, we anticipate the workforce demands for cultivators, GMP producers, processing manufacturers, security personnel and exportation consultants will continue to grow.
Who can help you start your medicinal cannabis business?
PharmOut’s cannabis consultants can assist you with licensing applications, medicinal marijuana processing and regulatory requirements for GMP / EU GMP (PIC/S).
Our pharmaceutical facility design architects, cleanroom validation, testing and processing engineers are experts in assisting cultivators and medicinal cannabis manufacturers with environmentally-minded designs for efficiency and GMP compliance. Contact PharmOut with your enquiry or view the medicinal cannabis cultivation support pages and 2020 cannabis conferences.
Founded in 2006, PharmOut is an experienced professional consultancy specialising in supporting the medicinal cannabis and pharmaceutical manufacturing industries with offices in Australia, Hong Kong, New Zealand, South Africa, United Kingdom and the United States.
PharmOut regularly guides clients through the rigorous licensing, permitting, GACP and GMP requirements of various international agencies.
Read the press release here.
REFERENCES and recommended reading
Page last updated on July 29, 2019.